Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase III double blind study of Bortezomib and Dex in combination with Venetoclax or Placebo in R/R MM
Clinical Trial Grant
Duke Scholars
Principal Investigator
Cristina Gasparetto
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
AbbVie Inc.
Start Date
October 1, 2016
End Date
September 30, 2022
Awarded By
AbbVie Inc.
Start Date
October 1, 2016
End Date
September 30, 2022
